-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new crown pneumonia infection clinical manifestations and prognosis significantly different from asymptomatic infection in critically ill patients with severe acute respiratory distress syndrome to occur, almost all organs and systems have been virus-free.
New coronary pneumonia infection At present, researchers have studied the acute symptoms of new coronary pneumonia infection very well, but they know little about the long-term sequelae of new coronary pneumonia.
Researchers have recently conducted a prospective uncontrolled cohort study.
COVID-19
A total of 834 patients were followed up at 4 months, and 478 were evaluated over the phone (mean age 61 years, 201 men).
During the telephone follow-up, 244 patients (51%) declared at least one symptom that did not exist before COVID-19 infection: fatigue accounted for 31%, cognitive symptoms accounted for 21%, and dyspnea accounted for 16%.
Sequelae of patients with new coronary pneumonia infection
According to the study, 4 months after hospitalization and recovery from new coronary pneumonia, more than half of the patients had sequelae, the abnormal rate of lung CT was as high as 60%, and fatigue and mobility were significantly reduced .
After 4 months of hospitalization and recovery from new coronary pneumonia, more than half of the patients had sequelae, and the abnormal rate of lung CT was as high as 60%.
The Writing Committee for the COMEBAC Study Group.
com/journals/jama/fullarticle/2777787" target="_blank" rel="noopener">Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
JAMA leaves a message here
